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ABSTRACT: Cryoprotective agents (CPAs) are typically solvents
or small molecules, but there is a need for innovative CPAs to
reduce toxicity and increase cell yield, for the banking and
transport of cells. Here we use a photochemical high-throughput
discovery platform to identify macromolecular cryoprotectants, as
rational design approaches are currently limited by the lack of
structure−property relationships. Using liquid handling systems,
120 unique polyampholytes were synthesized using photopolymerization with RAFT agents. Cryopreservation screening identified
“hit” polymers and nonlinear trends between composition and function, highlighting the requirement for screening, with polymer
aggregation being a key factor. The most active polymers reduced the volume of dimethyl sulfoxide (DMSO) required to
cryopreserve a nucleated cell line, demonstrating the potential of this approach to identify materials for cell storage and transport.
The distribution of cells as therapies, as proteinfactories,1−3 and in basic biomedical research is under-
pinned by their cryopreservation to enable storage and
distribution. This is essential as cells cannot be maintained
in continuous culture due to the resulting genetic and
phenotypic drift.4 Current cryopreservation protocols for
mammalian cells rely on the addition of high concentrations
of dimethyl sulfoxide (DMSO) as the cryoprotective agent
(CPA). While widely used, DMSO does not give full recovery
of all cells post-thaw (leading to wastage) and is intrinsically
cytotoxic (leading to further cell death if left in contact).5−7
DMSO does not protect against all mechanisms of cell death
(e.g., mechanical damage caused by ice recrystallization8). It is
therefore desirable to reduce the amount of DMSO used in
cryoprotective solutions. To address this issue, macromolecular
cryoprotectants inspired by antifreeze (glyco) proteins or late
embryogenesis abundant proteins are emerging.9−11 Polymers
which control ice recrystallization have been found to give
some benefit during cryopreservation of various cell lines, but
this effect is limited in mammalian cells.12 However, it is
emerging that polyampholytes (polymers with a balance of
cationic and anionic side chains) are extremely potent
cryopreservation enhancers despite only having moderate ice
recrystallization inhibition (IRI) activity13,14 compared to, e.g.,
poly(vinyl alcohol) or other inhibitors.15−17 Polyampholytes
have been shown to be remarkably potent cryoprotectants for
many cell types including mesenchymal stem cell (MSC)
monolayers,18 chondrocyte sheets,19 and human MSCs.20
However, their mode of action remains unclear, in part due
to the lack of structure−property relationships. There is some
evidence that polyampholytes engage and protect cell
membranes, but this is not proven as their mode of
cryoprotection.14,18
In any biomimetic material, a key challenge is the
exploration of sufficiently large chemical space (100s of
materials) to enable key structural motifs to be identified.
This is a particular challenge in macromolecular cryoprotec-
tants due to their diverse modes of action and paucity of
published structures of active materials. Alexander and co-
workers have used microarray printing and UV-photocuring to
explore 1000s of copolymers to identity surfaces suitable for
resisting bacterial adhesion and for the expansion of stem
cells.21 Schubert and co-workers exploited liquid handling
systems for automated cationic and radical polymerizations.22
However, this required significant infrastructure and robust
handling methods to exclude oxygen, which prematurely
terminates radical polymerizations. Recently, there has been
a revolution in oxygen-tolerant controlled radical polymer-
ization methods,23 for example, protein24 or tertiary amine
degassing,25 breathing ATRP,26 and PET-RAFT.27 A benefit of
these methods is that little infrastructure is required to conduct
the reactions in industry-standard multiwell plates; almost all
biological testing is conducted in 96-well plates. Richards et al.
utilized blue-light-initiated open-air RAFT photopolymeriza-
tion to identify new antimicrobial polymers.28 Chapman and
co-workers used oxygen-tolerant PET-RAFT to make a library
of 18 lectin binding materials.27 There are currently no
detailed structure−activity relationships in the field of
macromolecular cryoprotectants which is preventing the
rational design of new materials.
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This manuscript describes the first biomaterials discovery
approach to identify macromolecular cryoprotectants. Using
liquid-handling systems and photo-RAFT polymerization, a
library of polymers were synthesized, characterized, and
screened for cryopreservation. A new cryoprotectant terpol-
ymer was discovered which enabled nucleated cell cryopre-
servation with reduced [DMSO].
2-(Dimethylamino)ethyl methacrylate (DMEAMA) and
methacrylic acid (MAA) were selected as the cationic/anionic
components based on previous reports.14,29 Initial screening
(Supporting Information) identified that an excess of
DMEAMA compared to MAA leads to improved cryopre-
servation in an erythrocyte model, so a 6:4 DMEAMA:MAA
ratio was used. To enable high-throughput polymer synthesis,
liquid-handling robots were used to distribute reagents within
96-well plates, which is also the format for the cryopreservation
testing. Blue-light-mediated polymerization using a trithiocar-
bonate and triethanolamine (TEOA) as the degassing agent
was employed (Figure 1A).25,30 [Controls on the role of
TEOA are in Figures S4/5]. To tune the polyampholyte, a
panel of 12 (uncharged) comonomers were selected (Figure
1B). These were distributed by the liquid-handling system at
2−20 mol % with DMEAMA/MAA. An amount of 20 mol %
was the upper limit to ensure solubility of the library.
Polymerizations were conducted in 96-well plates under
blue-light irradiation and then dried under a vacuum. [Note
this method gives larger dispersities than a true CRP
process.31] A fraction was removed for size exclusion
chromatography (SEC), revealing monomodal distributions
and reproducible molecular weights within each polymer class
(Figure 1B and Table S2).
Erythrocytes (red blood cells) are a useful model system for
cryopreservation, as when damaged, heamoglobin leaks, which
can be measured by the alkaline hemeatin detergent (AHD)
assay, suitable for plate-based analysis.32 A sample of polymer
from the polymerization plate (at 140 mg·mL−1 in 700 μL of
PBS) was transferred directly into the corresponding wells of a
96-well plate and diluted to 71 mg·mL−1 by the addition of red
blood cells suspended in PBS. This mixture was then frozen in
liquid nitrogen vapor and thawed at 45 °C, and any intact cells
and debris were removed by centrifugation of the plate. The
supernatant was sampled into AHD solutions and hemolysis
measured on a plate reader at 580 nm. All 120 polymers were
assessed for cryopreservation capability in triplicate, and the
results are summarized in the heat map shown in Figure 2B.
Figure 2B reveals the essential need for high-throughput
screening in this emerging field; nonlinear relationships
between mol % comonomer and recovery were observed,
meaning hits would be missed when using traditional small
panels of polymers. For example, using comonomer 1 (PEG
methacrylate), at 8 or 14 mol %, led to increased recovery,
compared to 10 mol % which led to a significant reductiona
feature which could easily be missed in targeted synthesis.
Octanol/water partition coefficients, normalized to surface area
(log P/SA), were calculated using oligomers of the
comonomers and reported in Figure 2B,33,34 revealing no
clear correlation. This demonstrated that any assumptions of
“more hydrophobic is better” are oversimplified and limited by
the current lack of understanding of how polyampholytes
function.18,35 This should be appropriately described as
hydrophobicity is beneficial to a point and should be
experimentally verified.18 The most active polymer identified
contained 4 mol % of hydroxyethyl methacrylate (4), with
other levels of incorporation also giving significant cell
recovery. In contrast, the excessive hydrophobicity of cyclo-
hexyl methacrylate (11) resulted in the worst performance.
The best and worst polymers from the cryopreservation
screen (4% HEMA and 10% CyMA, respectively) were taken
forward to test in a nucleated cell model, using well-defined
polymers to validate the screening approach. The hit
terpolymers were synthesized targeting different DPs, using
conventional RAFT polymerization (Table 1 and Figure 3A),
and characterized by SEC, NMR, and IR (SI). In an
erythrocyte cryopreservation assay, these polymers performed
as in the screen (Figure 3C), confirming the initial results.
Importantly, the hit (4% HEMA) terpolymer was a better
cryoprotectant than the copolymer without additional
monomers (Figure S4).
Figure 1. (A) Combinatorial photopolymerization strategy employed
here. (B) SEC analysis of the polymer library. Number indicates
comonomer used. Polymers were synthesized at a [M]:[CTA] ratio of
100:1.
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A549 (human Caucasian lung carcinoma) cells were next
used as a more challenging model of cryopreservation to assess
the hit polymers, selected from the red blood cell
cryopreservation screen. A549 cryopreserved in 10 wt %
DMSO yields >60% recovery post-thaw. However, exposure of
A549s to 10 wt % of DMSO for just 30 min leads to a 30%
drop in metabolic activity.14 We therefore explored cryopre-
servation using just 2.5 wt % of DMSO with our polymers
added at 20 mg·mL−1 to explore their ability to rescue cell
recovery in minimal DMSO. After thawing, the cells were
allowed to recover for 24 h before the total number of viable
cells was counted (Figure 3D). [24 h recovery post-thaw
removes false positives due to apoptosis.]36 Copolymers with
4% HEMA showed enhancements in post-thaw cell recovery
increasing from 15% for DMSO (2.5 wt %) to above 40%. In
contrast, the 10% CyMA copolymers gave worse results than
DMSO alone. This shows that polyampholytes are not
universal scaffolds and that additional structural features
modulate activity. DP100 HEMA was more potent than
DP50 or 200 showing that the macromolecular structure is
important with the longer polymer performing poorly in this
assay. Figure 3E (and S10/11) shows oligomer models of the
most/least active copolymers and the segmental LogP/SA
values (rather than a crude average across the whole polymer).
Localized regions of hydrophobic content (positive log P/SA)
correlated with poor cell recovery, but hydrophilic regions
exhibited better performance. This observation may explain
why alternating (evenly distributed hydrophobicity) poly-
ampholytes are potent cryopreservatives and also have more
IRI activity compared to random.13,14 None of the polymers
showed significant IRI activity16 (Figure 3B) ruling out ice-
growth inhibition as a mode of action.37 The recoveries
obtained here are not as high as a previously reported
poly(ampholyte)14 but rather show the opportunity to
modulate activity and determine the important structural
features. Dynamic light scattering (DLS) showed that 10%
CyMA polymers aggregated but that the 4% HEMA aggregated
less. This demonstrates that although hydrophobicity can help,
Figure 2. High-throughput screening of cryopreservation against
erythrocytes. (A) Schematic of liquid transfer and screening
conditions. (B) Heat map showing post-thaw erythrocyte recovery
outcomes (recovery = 1-heamolysis) using 71 mg·mL−1 of polymer.
Recoveries are average of three repeats (individual data in SI).
Monomer structures are in Figure 1.
Table 1. Hit Polymers Synthesized by RAFT
polymera
[M]/[CTA]b
(−)
conversion
(%)c
Mn(Theo)
d
(g mol−1)
Mn(SEC)
e
(g mol−1) D̵e
4%
HEMA50
50 100 6400 10 000 1.48
4%
HEMA100
100 97 12 000 15 000 1.57
4%
HEMA200
200 98 25 000 15 000 1.84
10%
CyMA100
100 96 12 000 16 000 1.39
aPolymers labeled based on comonomer incorporation ratio into a 6:4
DMEAMA:MA copolymer. bMonomer:CTA ratio. cDetermined by
1H NMR. dBased on feed ratio and conversion. eFrom DMF SEC.
Figure 3. Hit polymers and their cryoprotective properties. (A)
Polymers obtained by conventional RAFT polymerization. (B) Ice
recrystallization inhibition activity of hit polymers (20 mg·mL−1,
MGS = mean grain size, dotted line = PEG 20 mg·mL−1 control). (C)
Red blood cell post-thaw recovery. (D) Post-thaw recovery of A549
cells with intact membranes using 2.5 wt % of DMSO/20 mg·mL−1 of
polymer against control of 2.5 wt % of DMSO alone. (E) Segmented
partition coefficient analysis. Colors represent monomers in Part A.
Squares are HEMA; triangles are CyMA; and circles are DMAEMA/
MAA. Highlighted areas show net positive or negative log P/SA.
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aggregation negates the benefits: this could lead to reducing
the effective concentrations of the polymers or simply
preventing efficient membrane interactions (a hypothesis we
highlight is not confirmed).
To further test how the polymers protect cells, carboxy-
fluorescein-loaded 1,2-dioleoyl-sn-glycero-3- phosphocholine
liposomes (100 nm) were prepared (Supporting Information)
to enable evaluation of cryoprotection in a lipid-only system.
The most active cellular cryoprotectant (4% HEMA100)
protected liposomes against freezing, equally well as a control
polyampholyte (Figure S9). The most hydrophobic polymer
(10% CyMA100) failed to provide protection, which is in
contrast to the results of Matsumura et al.18 This does not rule
out hydrophobicity being beneficial but rather that multiple
factors are influencing cryopreservation outcomes including
the aggregation state of the materials, and hence a fine balance
is required. Antifreeze proteins have been reported to protect
membranes and may be a related mechanism of action.38
Osmotic effects on cryopreservation due to the use of a
polyelectrolyte cannot be ruled out. However, the clear impact
of comonomers and chain length on the observed
cryopreservation outcomes suggests it is more complex and
that a single mechanism may not be responsible.
In summary, we have used a high-throughput discovery
platform to identify polyampholyte terpolymers, which are
capable of reducing the volume of organic solvents required for
cellular cryopreservation. High-throughput oxygen-tolerant
photo-RAFT polymerization generated a library of 120
polyampholytes. Screening of this library for red blood cell
cryopreservation enabled identification of hits, with terpol-
ymers containing just 4 mol % of hydroxyethyl methacrylate
showing particularly high activity. “Hit” terpolymers enhanced
cryopreservation of a nucleated cell model using just 2.5 wt %
of DMSO, rather than the conventional 10 wt %. The polymers
did not function by inhibiting ice growth, but there was some
evidence that they can stabilize model membranes. Modeling
showed that the most active polymers had negative surface-
area-normalized partition coefficients across most segments.
Overall, this study shows that by exploring the chemical space
of polyampholytes it may be possible to discover new
macromolecular cryoprotectants and access structure−prop-
erty relationships to help understand how they function.
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